Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease

1 Jan 2008

Abstract excerpt

The identification of biological markers of Alzheimer's disease (AD) can be extremely useful to improve diagnostic accuracy and/or to monitor the efficacy of putative therapies. In this regard, peripheral cells may be of great importance because of their easy accessibility. After subjects were grouped according to diagnosis, the expression of conformational mutant p53 in blood cells was compared by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cancer-related Molecular Pathways
Share to Nuclear Receptors and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18322392
DOI: 10.1159/000113704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s DiseasePMID 18322392Read ↗

Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.Semantic proximity Read ↗

Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease.Semantic proximity Read ↗

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s diseaseSemantic proximity Read ↗

A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer's DiseaseSemantic proximity Read ↗

Discovery of Simple Blood-Based Test to Predict Early Onset of Alzheimer’s Using Standard Clinical Mass Spectrometry PlatformsSemantic proximity Read ↗

Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53.Semantic proximity Read ↗

Performance of a Non-Invasive Blood Test for a Conformational Variant of p53 to Predict Alzheimer’s Disease Within 6 Years of Clinical DiagnosisSemantic proximity Read ↗

A conformational variant of p53 (U-p53<sup>AZ</sup>) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s diseaseSemantic proximity Read ↗

Toward an Early Diagnosis for Alzheimer’s Disease Based on the Perinuclear Localization of the ATM ProteinSemantic proximity Read ↗

Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein Parkinson’s diseaseSemantic proximity Read ↗

Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.